National Institute on Alcohol Abuse and Alcoholism (NIAAA)

The Division of Treatment and Recovery (DTR) is an extramural NIAAA Division that focuses on developing treatments for alcohol use disorder (AUD), increasing their use in real-word settings, and understanding the process of recovery as individuals make progress in overcoming AUD. The Division is comprised of two branches: the Medications Development Branch (MDB) and the Treatment, Health Services, and Recovery...

Harassment and Discrimination Protections in NIH Training Applications Applications for National Institutes of Health (NIH) institutional training grants (T15, T32, T34, T35, T36, T37, T90/R90, TL1, TL4) must include a letter on institutional letterhead signed by a key institutional leader that describes the institutional commitment to ensuring that proper policies, procedures, and oversight are in place to prevent discriminatory harassment...

Fri, 02/10/2023 - 12:00

This article was first published in NIAAA Spectrum Volume 15, Issue 1. Drinking too much—whether on a single occasion or over many years—can take a serious toll on an individual’s health. Clinicians across the health care spectrum can play important roles in preventing and treating the harmful effects of alcohol. This role is particularly important among providers who manage patients...

Flying footballs, couch potato mice, and what can happen with explosive-propelled iron spikes are just a few of the interactive tools that scientists from the National Institutes of Health used to teach young people about the amazing human brain at the National Museum of Health and Medicine in Silver Spring, Md., on March 14 and 15. The NIH activities are...

Cross-cutting research programs are NIAAA-managed research portfolios that include topics spanning multiple research goals outlined in this strategic plan. These programs complement the Cross-Cutting Research Themes and Supporting the Mission sections of this strategic plan. Fetal Alcohol Spectrum Disorders Fetal alcohol spectrum disorders (FASD) represent the broad range of neurodevelopmental impairments and other physical effects that result from prenatal exposure...

Wednesday, June 8, 2011 - Thursday, June 9, 2011

NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM Summary of the 127th Meeting June 8-9, 2011 The National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA) convened for its 127th meeting at 5:30 p.m. on June 8, 2011, at the Fishers Lane Conference Center in Rockville, Maryland, in closed session for a review of grant applications. The meeting recessed at...

2022 National Conference on Alcohol and Other Substance Use in Women and Girls: Advances in Prevention, Treatment and Recovery October 20-21, 2022 CONFERENCE AGENDA DAY 1: Thursday, October 20, 2022 8:00 a.m.–8:10 a.m. ET Welcome & Introductions Deidra Roach, M.D., Program Director, Treatment, Health Services, and Recovery Branch, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health...

April 23-24, 1998 • Ramada Inn • Bethesda, Maryland Abstracts Substance Abuse in Pregnant Women Richard S. Schottenfeld, M.D. From the Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut The objective of this program was to evaluate the prevalence, patterns, and correlates of tobacco, alcohol, marijuana, and cocaine use during pregnancy in an urban hospital prenatal clinic...

What we do The Clinical NeuroImaging Research Core (CNIRC) serves two functions: Conducting independent addiction neuroimaging and psychophysiological studies and providing expertise in these areas, through collaborations and support to clinical investigators. We are looking to add a post-doctoral researcher to our team. Learn about the position and how to apply. Research interests include: Investigate the neural correlates of cognition...

George Kunos MD. , PhD. Chief National Institute on Alcohol Abuse and Alcoholism National Institutes of Health 5625 Fishers Lane, Room 2S-24:MSC 9413 Bethesda MD 20892-9413 telephone: +1 301.443.2069 fax: +1 301.480.0257 e-mail: gkunos@mail.nih.gov Mission Statement The Biology and Functions of the Endocannabinoid System Endocannabinoids are lipid-like mediators discovered in the 1 990s that bind to cannabinoid receptors to trigger...

CAPT Joseph R. Hibbeln, MD, Acting Chief National Institute on Alcohol Abuse and Alcoholism National Institutes of Health 5625 Fishers Lane, Room 3N07:MSC 9410 Bethesda MD 20892-9410 telephone: 301.594.3034 fax: +1 301.402.4617 e-mail: jhibbeln@mail.nih.gov Overview | Lab Members | Alumni | Videos | Projects | Publications No positions for training or employment are available within The Section on Nutritional Neurosciences...

Thursday, December 13, 2012

The National Advisory Council on Alcohol Abuse and Alcoholism, National Advisory Council on Drug Abuse, and National Cancer Advisory Board convened for their first joint meeting at 11:30 a.m. on December 13, 2012. The meeting originated at National Institutes of Health (NIH), Bethesda, Maryland, chaired by Dr. Lawrence A. Tabak, Principal Deputy Director, NIH. National Advisory Council on Alcohol Abuse...

Mechanisms for mitochondrial dysfunction and apoptosis in alcoholic and nonalcoholic fatty liver and tissue injury – Dr. Song and his lab members have studied regulations and roles of the two enzymes involved in metabolism of alcohol and acetaldehyde: the ethanol-inducible cytochrome P450 2E1 (CYP2E1) and mitochondrial aldehyde dehydrogenase (ALDH2). In particular, the functional implications of increased CYP2E1 and decreased ALDH2...

In this "First Steps to Al-Anon Recovery" podcast, you will hear an interview with Dr. George Koob, Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), as he discusses the impacts of alcoholism on family members and friends. For more reasons to try Al-Anon, visit al-anon.org. Al-Anon members: Please remember to maintain anonymity in your comments and don't...

LIVER CIRRHOSIS MORTALITY IN THE UNITED STATES: NATIONAL, STATE, AND REGIONAL TRENDS, 2000–2019 Chiung M. Chen, M.A. Young-Hee Yoon, Ph.D. CSR, Incorporated 1 Suite 220 22375 Broderick Drive Sterling, VA 20166 February 2022 U.S. Department of Health and Human Services Public Health Service National Institutes of Health 1 CSR, Incorporated, operates the Alcohol Epidemiologic Data System (AEDS) under Contract No...

The mission of the lab is to understand the cellular and molecular mechanisms involved in the development and progression of fibrosis, to explore novel therapeutic targets and to develop effective pharmacotherapies for fibrotic disorders of different etiologies, including alcohol use disorders. We are particularly interested in pursuing a multi-target therapeutic approach to improve treatment efficacy by simultaneously engaging multiple pathogenic...

Alcohol-Related Emergency Department Visits and Hospitalizations and Their Co-Occurring Drug-Related, Mental Health, and Injury Conditions in the United States: Findings from the 2006–2010 Nationwide Emergency Department Sample (NEDS) and Nationwide Inpatient Sample (NIS) September 2013 National Institutes of Health National Institute on Alcohol Abuse and Alcoholism 5635 Fishers Lane, MSC 9304 Bethesda, MD 20892‑9304 Acknowledgments This publication was developed by...

At some time during their lives, more than 30 percent of U.S. adults surveyed in 2001-2002 had met current diagnostic criteria [i] for an alcohol use disorder (AUD), according to an article in the current issue of the Archives of General Psychiatry . Many of those persons never received treatment, and many others did not receive treatment until well after...

What we do The Section on Clinical Genomics and Experimental Therapeutics (CGET) conducts pre-clinical studies and translational clinical studies with focus on genomics and epigenetics related to the pathophysiology and treatment of alcohol use disorders and addictions. The pre-clinical work focuses on identifying molecular mechanisms involved in addictions, utilizing a wide array of methods including human population genetics, genome wide...

Helping Your Patients with Alcohol-Related Problems. Alcohol contributes to more than 200 health conditions and about 99,000 deaths in the U.S. each year. Yet alcohol-related risks often go unaddressed in healthcare settings.